No abstract

No abstract

No abstract

To explore new models of payment and benefit designs for high-investment medications, the AMCP convened a stakeholder conference in Baltimore Maryland on July 24 and 25, 2018. Health care leaders representing health plans, integrated delivery systems, pharmacy benefit managers, employers, national professional associations, the federal government, and biopharmaceutical companies participated in the forum. The forum stakeholders engaged in thoughtful discussions regarding innovative payment strategies for high-investment medications, and challenges and opportunities when evaluating strategies to provide compensation for breakthrough treatments that require high investments.

No abstract